Evaluation of Cytokine-induced Killer (CIK) Cells as Therapy or Adjuvant Treatment for Advanced HCC

NCT02568748 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Liver Cancer

Interventions

BIOLOGICAL: CIK
PROCEDURE: TACE

Sponsor

Sherief Abd-Elsalam

Collaborators

[object Object]